Search clinical trials for: XIENCE PRIME SV EECSS

Total 49 results

Abbott Medical Devices

Completed

A Clinical Evaluation of the XIENCE PRIME Small Vessel Everolimus Eluting Coronary Stent System in Japanese Population (SV JAPAN)

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Coronary Restenosis | Vascular Disease | Coronary Artery Stenosis

Japan
Abbott Medical Devices

Completed

XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval Randomized Control Trial (RCT)

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Coronary Occlusion | Coronary Restenosis | Vascular Disease | Coronary Artery Stenosis | Thrombosis (Stent Thrombosis)

China
Lepu Medical Technology (Beijing) Co., Ltd.

Unknown

NeoVas Bioresorbable Coronary Scaffold Randomized Controlled Trial

Coronary Artery Disease

China
Abbott Medical Devices

Completed

SPIRIT PRIME Clinical Trial (SPIRIT PRIME)

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Coronary Restenosis | Coronary Artery Stenosis

United States, Australia
Abbott Medical Devices

Completed

XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS) China Single-Arm Study (XP China SAS)

Myocardial Infarction | Coronary Artery Disease | Cardiovascular Disease | Coronary Heart Disease | Stent Thrombosis | Coronary Restenosis | Vascular Disease | Angioplasty

United States
Abbott Medical Devices

Completed

XIENCE PRIME Japan Post-Marketing Surveillance (PMS)

Myocardial Ischemia | Coronary Artery Disease | Coronary Occlusion | Coronary Artery Stenosis | Angina

Japan
Deutsches Herzzentrum Muenchen
Technical University of Munich

Completed

ORSIRO Stents Versus Xience PRIME Stents Assessed by Optical Coherence Tomography (ORSIRO_OCT)

Coronary Heart Disease

Germany
Amsterdam UMC, location VUmc

Unknown

Impact of Vascular Reparative Therapy on Vasomotor Function and Myocardial Perfusion:a Randomized H215O PET/CT Study (VANISH)

Coronary Artery Disease

Netherlands
Abbott Medical Devices

Completed

XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA Long Term Follow-up Cohort) (XVU-LTF)

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Coronary Restenosis | Chronic Coronary Occlusion | Vascular Disease | Coronary Artery Stenosis

United States
Kobe University
Marquette University

Unknown

Relation Among Shear Stress Distribution, Stent Design, and Subsequent Vessel Healing After Drug-eluting Stent Implantation (SHEAR DES)

Coronary Heart Disease

Japan
Policlinico Casilino ASL RMB
Azienda Ospedaliero-Universitaria di Modena

Withdrawn

Outcome of Second Generation Drug-eLuting Stents in Patients With Diabetes Mellitus (OCELOT)

Coronary Artery Disease | Diabetes Mellitus

Italy
Abbott Medical Devices

Completed

XIENCE V: SPIRIT WOMEN

Myocardial Ischemia | Coronary Artery Disease | Coronary Arteriosclerosis | Stent Thrombosis | Vascular Disease | Coronary Artery Stenosis | Total Coronary Occlusion | Coronary Artery Restenosis

France, Italy, Norway, China, Spain, Germany, United Kingdom, Switzerland, Israel, Denmark, Belgium, Austria, Poland, Australia, Portugal, Argentina, Brazil, Hungary, Latvia, Netherlands, India, Greece, Malaysia, Russian Federation, South... and more
Abbott Medical Devices

Completed

A Clinical Evaluation of Absorb™ Bioresorbable Vascular Scaffold (Absorb™ BVS) System in Chinese Population ~ ABSORB CHINA Randomized Controlled Trial (RCT) (ABSORB CHINA)

Coronary Artery Disease | Coronary Disease | Coronary Stenosis | Coronary Artery Stenosis

United States
Kobe University

Unknown

Multicenter Comparison of Early and Late Vascular Responses to Everolimus-eluting Cobalt-CHromium Stent

Coronary Artery Disease

Japan
Abbott Medical Devices

Completed

SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Coronary Artery Lesions (Diabetic Sub-Study)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

Netherlands, Thailand, Israel, Spain, Italy, United Kingdom, Malaysia, Austria, France, Germany, Poland
Sino Medical Sciences Technology Inc.

Completed

A Comparative Evaluation of the Extent of Neointima Formation at 1 Month and 2 Months After Implantation Using OCT

Coronary Artery Disease | Stable Angina Pectoris | Unstable Angina Pectoris

China
Abbott Medical Devices

Completed

XIENCE V: SPIRIT WOMEN Sub-study

Myocardial Ischemia | Coronary Artery Disease | Coronary Arteriosclerosis | Stent Thrombosis | Vascular Disease | Coronary Artery Stenosis | Total Coronary Occlusion | Coronary Artery Restenosis

Italy, Norway, Switzerland, Denmark, Spain, Poland, Belgium, Argentina, Austria, Brazil, France, Germany, Hungary, Latvia, Netherlands
Abbott Medical Devices

Completed

AVJ-301 Clinical Trial: A Clinical Evaluation of AVJ-301 (Absorb™ BVS) in Japanese Population (ABSORB JAPAN)

Myocardial Ischemia | Coronary Artery Disease

Japan
Aarhus University Hospital Skejby
Medtronic; Abbott Medical Devices

Unknown

The Does Optical Coherence Tomography Optimize Revascularization (DOCTOR) Recross Study (DOCTOR Recross)

Coronary Disease

United Kingdom, Belgium, Denmark
Flanders Medical Research Program

Completed

Drug Eluting Stents In The Critically Ischemic Lower Leg 2 (DESTINY 2)

Peripheral Arterial Disease

Germany, Australia, Belgium
Seung-Jung Park
Abbott; CardioVascular Research Foundation, Korea

Terminated

LONG-DES VI (Drug Eluting Stent for Long Lesions in Coronary Artery)

Coronary Artery Disease

Korea, Republic of
Biotronik AG

Unknown

Study of the Orsiro Drug Eluting Stent System (BIOFLOW-II)

Coronary Artery Disease

Latvia, Germany, Spain, Switzerland, Austria, France, Hungary, Netherlands
Abbott Medical Devices

Completed

XIENCE PRIME SV Everolimus Eluting Coronary Stent Japan Post Marketing Surveillance (XIENCE PRIME SV Japan PMS)

Myocardial Ischemia | Coronary Artery Disease | Angina Pectoris | Ischemic Heart Disease | Coronary Artery Occlusion

Japan
Sydney South West Area Health Service

Unknown

IVUS Controlled Stenting

Coronary Angioplasty and Stenting | Single de Novo Coronary Artery Stenoses

Australia
Seoul National University Hospital

Completed

Korean Nationwide Multicenter Pooled Registry of Drug-Eluting Stents (Grand-DES)

Coronary Artery Disease

Korea, Republic of
European Cardiovascular Research Center

Unknown

Trial to Assess the Everolimus-Eluting Coronary Stent System (PROMUS Element) for Coronary Revascularization (PLATINUM+)

Ischemic Heart Disease | Coronary Artery Stenosis

Spain, Germany, France, United Kingdom, Italy, Netherlands, Macedonia, The Former Yugoslav Republic of, Switzerland
Abbott Medical Devices

Terminated

ABSORB PHYSIOLOGY Clinical Investigation

Coronary Artery Disease

Netherlands, Australia, Singapore, China
Universitaire Ziekenhuizen KU Leuven
Biosensors International

Unknown

COmplex BifuRcation Lesions: a Comparison Between the AXXESS Device and Culotte Stenting: an Optical Coherence Tomography (OCT) Study (COBRA)

True Coronary Bifurcation Lesions

Belgium
Academisch Medisch Centrum - Universiteit van Amsterdam...

Unknown

Amsterdam Investigator-initiateD Absorb Strategy All-comers Trial (AIDA)

Myocardial Infarction | Coronary Artery Disease

Netherlands
Abbott Medical Devices

Completed

XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval, Single-Arm Study (XV CHINA SAS)

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Stent Thrombosis | Coronary Restenosis | Chronic Coronary Occlusion | Vascular Disease | Coronary Artery Stenosis | Angioplasty

United States
R&D Cardiologie
Biotronik SE & Co. KG

Unknown

Hybrid Sirolimus-eluting Versus Everolimus-eluting Stents for Total Coronary Occlusions (PRISON-IV)

Coronary Artery Disease | Coronary Disease | Coronary Stenosis

Netherlands, Belgium
Shanghai Bio-heart Biological Technology Co., Ltd.
CCRF Inc., Beijing, China

Active, not recruiting

Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System Clinical Study

Coronary Artery Disease | Antineoplastic Agents

China
University Hospital Heidelberg

Completed

Procedural Advantages of a Novel Drug-Eluting Coronary Stent

Coronary Artery Disease
Iwate Medical University

Completed

Multicenter Comparison of Early and Late Vascular Responses to Everolimus-eluting Cobalt-CHromium Stent and Platelet AggregatioN studIeS for TreatMent of Acute Myocardial InfarctionTreatment of ST-elevation Acute Myocardial Infarction (MECHANISM-AMI)

Coronary Artery Disease

Japan
Chonbuk National University Hospital

Unknown

COmparison of Xience PrimE Versus REsolute Integrity in Diabetes or Small Vessel Disease (COPERES)

Angioplasty, Balloon, Coronary

Korea, Republic of
A.O. Ospedale Papa Giovanni XXIII
Light Lab Imaging, Inc.

Completed

Optical Coherence Tomography Assessment of Gender diVersity In Primary Angioplasty: The OCTAVIA Trial (OCTAVIA)

Acute Myocardial Infarction
Yonsei University

Unknown

Assessment of Stent Malapposition and Neointimal Coverage on Optical coHerence Tomography at Post-procedure and 3 Months After Platinum Chromium Alloy Of the Element™ Stent Implantation (ANCHOR)

Coronary Artery Disease

Korea, Republic of
University Hospital, Basel, Switzerland

Completed

Safety and Efficacy Study Comparing 3 New Types of Coronary Stents

Coronary Artery Disease | Coronary Thrombosis

Denmark, Austria, Germany, Switzerland
San Giuseppe Moscati Hospital

Completed

Bioresorbable Vascular Scaffold in Patients With Myocardial Infarction

ST Elevation Acute Myocardial Infarction

Italy
Cordis Corporation

Terminated

An Observational Safety Evaluation of Patients Treated With the NEVO™ Sirolimus-eluting Coronary Stent. (NEVO II) (NEVO II)

Atherosclerotic Coronary Artery Disease

Spain, Switzerland, Netherlands
Meshalkin Research Institute of Pathology of Circulation

Completed

Sirolimus-eluting Stent CALYPSO vs Everolimus-eluting Stent XIENCE (PATRIOT)

Coronary Artery Disease | Ischemic Heart Disease | Coronary Atherosclerosis | Coronary Artery Stenosis

Russian Federation
Abbott Medical Devices

Active, not recruiting

XIENCE Skypoint Large Vessel Post Approval Study (SPIRIT XLV PAS)

Coronary Artery Disease

United States, Spain, France
Yonsei University
Gangwon Cardiovascular Health Research Institute

Terminated

BES, EES, and ZES-R in Real World Practice (CHOICE)

Coronary Artery Disease

Korea, Republic of
Fortis Escorts Heart Institute
Boston Scientific Corporation; Max Neeman Medical International Ltd.

Completed

Trial on Safety & Performance of TAXUS Element vs. XIENCE Prime Stent in Treatment of Coronary Lesion in Diabetics (Tuxedo)

Type 2 Diabetes | Coronary Heart Disease

India
Abbott Medical Devices
Bristol-Myers Squibb; Eli Lilly and Company; Daiichi Sankyo, Inc.; Baim Institute...

Completed

XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort (XVU-AV DAPT)

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Chronic Total Occlusion of Coronary Artery | Coronary Restenosis | Vascular Disease | Coronary Artery Stenosis

United States
CCRF Consulting Co., Ltd.

Unknown

A Registry To Evaluate Safety And Effectiveness Of Everolimus Drug Eluting Stent For Coronary Revascularization (SEEDS)

Coronary Artery Diseases

China
Yonsei University

Completed

Serial EValuation of multiplE Coronary Artery Diseases by an Optical Coherence Tomography; Assessment of the Changes of de Novo Lesions and Comparisons of Neointimal Coverage Between Xience Prime® Versus Cypher SelectTM Stents; SEVEN-Xience Study

Multi-vessel Diseases, Angina

Korea, Republic of
CHEOL WHAN LEE, MD, PhD.
CardioVascular Research Foundation, Korea

Completed

Comparison of Cilotax Stent and Everolimus -Eluting Stent With Diabetes Mellitus (ESSENCE-DM III)

Coronary Artery Disease

Korea, Republic of
National Taiwan University Hospital

Unknown

Imaging and Interventional Study for Erectile Dysfunction and Lower Urinary Tract Symptoms (PERFECT)

Lower Urinary Tract Symptoms | Peripheral Arterial Disease | Erectile Dysfunction

Taiwan

Search clinical trials for: XIENCE PRIME SV EECSS

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Türkiye

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations